MINNEAPOLIS/ST. PAUL — In a major scientific breakthrough, newly published research from an international consortium led by the University of Minnesota’s Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment. Published today in JAMA Network Open, the findings indicate that ovarian cancer patients with high levels...
Latest News
Columbia, Missouri – New research at the Roy Blunt NextGen Precision Health building has discovered a potential treatment for an underlying cause of cardiovascular disease in people with Type 2 diabetes. More than 30 million Americans live with Type 2 diabetes. One common feature of diabetes is the hardening and...
Münster, Germany – In a transformative study published in the Journal Science Translational Medicine, an international team of researchers, led by the University of Münster and Department of Neurology at the University Hospital of Münster, Germany, in collaboration with the German Competence Network Multiple Sclerosis (KKNMS), has made a significant...
CHAPEL HILL, N.C. – UNC School of Medicine researcher Sarah Cohen, PhD, and Ian Windham, a former PhD student from the Cohen lab, have made a new discovery about apolipoprotein E (APOE) – the biggest genetic risk factor for late-onset Alzheimer’s disease. Older people who inherited a genetic variant called...
NORMAN, Oklahoma – In the past year, three researchers at the University of Oklahoma College of Medicine at OU Health Sciences have earned more than $5 million in grant money to study causes and potential treatments for necrotizing enterocolitis, a deadly intestinal disease that primarily affects infants born prematurely. Because...
Norman, Oklahoma – Like alien invaders in a sci-fi movie, pancreatic cancer cells quickly adapt to the weapons used against them and find ways to survive, even in the harshest of conditions. Understanding why is the aim of cancer scientists everywhere. A University of Oklahoma researcher recently advanced the knowledge...
Ottawa, Canada – A University of Ottawa neuroscientist’s personal battle with cancer has inspired new research geared toward tailoring radiation treatment to reduce damage to the brain. Cancer treatments – including radiation therapy – can have debilitating effects on patients, weakening the immune system and leading to memory and cognitive...
Ottawa, Canada – Glioblastoma is the most common – and the most malignant – primary brain tumour in adults. It’s aggressive and incurable. Even with treatment including surgical removal and chemotherapy, the median survival for patients is just 18 months. Now, innovative new research led by Dr. Arezu Jahani-Asl, Canada Research Chair in Neurobiology of...
Ottawa, Canada – A team from the University of Ottawa’s Faculty of Medicine has completed an exciting new study that reveals the inner workings of gene mutations that result in an ultra-rare syndrome with fewer than 100 reported cases since its first description in the early 1960s. The hard-won research...
Philadelphia, PA – Researchers from the University of Pennsylvania, Perelman School of Medicine, Gene Therapy Program, and Moderna, have shown that repeated administration of lipid nanoparticle-encapsulated mRNA therapy significantly extended survival and reduced serum leucine levels in a mouse model of maple syrup urine disease (MSUD). Click here to read...